Plancorp LLC reduced its stake in shares of The Macerich Company (NYSE:MAC - Free Report) by 33.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,549 shares of the real estate investment trust's stock after selling 16,300 shares during the period. Plancorp LLC's holdings in Macerich were worth $648,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of the stock. Quantbot Technologies LP bought a new stake in Macerich in the fourth quarter worth approximately $30,000. Blue Trust Inc. boosted its holdings in Macerich by 68.8% in the fourth quarter. Blue Trust Inc. now owns 2,610 shares of the real estate investment trust's stock worth $48,000 after purchasing an additional 1,064 shares in the last quarter. Smartleaf Asset Management LLC increased its position in Macerich by 314.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 3,467 shares of the real estate investment trust's stock worth $69,000 after buying an additional 2,630 shares during the last quarter. GAMMA Investing LLC raised its holdings in Macerich by 36.5% during the fourth quarter. GAMMA Investing LLC now owns 4,388 shares of the real estate investment trust's stock valued at $87,000 after buying an additional 1,174 shares in the last quarter. Finally, Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Macerich in the fourth quarter worth about $99,000. 87.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MAC has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft assumed coverage on Macerich in a research note on Tuesday, December 17th. They issued a "hold" rating and a $22.00 price objective on the stock. Scotiabank dropped their target price on shares of Macerich from $22.00 to $21.00 and set a "sector perform" rating on the stock in a report on Thursday, March 6th. Morgan Stanley raised Macerich from an "underweight" rating to an "equal weight" rating and set a $20.00 price target on the stock in a research report on Wednesday, January 15th. The Goldman Sachs Group cut their price objective on Macerich from $16.70 to $14.40 and set a "sell" rating for the company in a research report on Monday, March 10th. Finally, Piper Sandler lowered their target price on Macerich from $17.00 to $16.00 and set an "underweight" rating on the stock in a report on Friday, February 28th. Four research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $19.49.
Check Out Our Latest Stock Analysis on MAC
Macerich Price Performance
Shares of MAC stock traded down $0.09 during mid-day trading on Thursday, reaching $17.32. The company's stock had a trading volume of 1,368,886 shares, compared to its average volume of 1,839,642. The company has a debt-to-equity ratio of 1.68, a quick ratio of 0.92 and a current ratio of 0.92. The firm's 50-day moving average is $19.13 and its two-hundred day moving average is $19.15. The Macerich Company has a 1-year low of $12.99 and a 1-year high of $22.27. The company has a market cap of $4.37 billion, a P/E ratio of 44.40, a PEG ratio of 0.71 and a beta of 2.62.
Macerich Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 3.93%. The ex-dividend date was Tuesday, March 4th. Macerich's dividend payout ratio is -86.08%.
Macerich Profile
(
Free Report)
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
See Also

Before you consider Macerich, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Macerich wasn't on the list.
While Macerich currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.